Viruses and interferon: a fight for supremacy
The DOI matches its Crossref record; 139 of the 139 references it cites were found in a registry or an index.
Abstract
The action of interferons (IFNs) on virus-infected cells and surrounding tissues elicits an antiviral state that is characterized by the expression and antiviral activity of IFN-stimulated genes. In turn, viruses encode mechanisms to counteract the host response and support efficient viral replication, thereby minimizing the therapeutic antiviral power of IFNs. In this review, we discuss the interplay between the IFN system and four medically important and challenging viruses -- influenza, hepatitis C, herpes simplex and vaccinia -- to highlight the diversity of viral strategies. Understanding the complex network of cellular antiviral processes and virus-host interactions should aid in identifying new and common targets for the therapeutic intervention of virus infection. This effort must take advantage of the recent developments in functional genomics, bioinformatics and other emerging technologies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A pivotal study in 1987 reported that a subpopulation of people with viral hepatitis treated with interferon (IFN) α — a pro-inflammatory anti-viral cytokine13 — developed depression14, demonstrating that a pro-inflammatory molecule in the periphery could directly influence mood.”
From Central regulation of stress-evoked peripheral immune responses (2023) · cites this paper as [13]
In the citing paper
“The ISG expression of all monocytes combined and all macrophages combined was higher in HCV infection compared with NS–SS and MASH (Extended Data Fig. 4e), consistent with the role of ISGs as antiviral effectors11.”
In the citing paper
“Neutrophil recruitment is induced mainly by epithelium-derived IL-8/CXCL8, Gro-α/CXCL1, and ENA-78/CXCL5 (142, 178, 223).”
From The airway epithelium: soldier in the fight against respiratory viruses (2011) · cites this paper as [142]
Citations
Cites
Massagué, J. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.753 · Cited by 7,556
Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3
Alexopoulou, L., Holt, A. C., Medzhitov, R., & Flavell, R. A. (2001) · Nature · doi:10.1038/35099560 · Cited by 6,129
A comprehensive analysis of protein–protein interactions in Saccharomyces cerevisiae
Uetz, P., Giot, L., Cagney, G., Mansfield, T. A., Judson, R. S., Knight, J. R., Lockshon, D., Narayan, V., Srinivasan, M., Pochart, P., et al. (2000) · Nature · doi:10.1038/35001009 · Cited by 4,706 · cited 1×
“, and to characterize global protein–protein interaction networks in an organis”
BackgroundVirus interference. I. the interferon
Isaacs, A., & Lindenmann, J. (1957) · Proceedings of the Royal Society of London. Series B - Biological Sciences · doi:10.1098/rspb.1957.0048 · Cited by 3,451
Toll-like receptors in the induction of the innate immune response
Aderem, A., & Ulevitch, R. J. (2000) · Nature · doi:10.1038/35021228 · Cited by 3,064
Replication of Subgenomic Hepatitis C Virus RNAs in a Hepatoma Cell Line
Lohmann, V., Körner, F., Koch, J.-O., Herian, U., Theilmann, L., & Bartenschlager, R. (1999) · Science · doi:10.1126/science.285.5424.110 · Cited by 2,814
Antiviral Actions of Interferons
Samuel, C. E. (2001) · Clinical Microbiology Reviews · doi:10.1128/cmr.14.4.778-809.2001 · Cited by 2,743 · cited 1×
“gif" NDATA ITEM> ]> Interferons (IFNs), although best known for their antiviral propertie”
Integrated Genomic and Proteomic Analyses of a Systematically Perturbed Metabolic Network
Ideker, T., Thorsson, V., Ranish, J. A., Christmas, R., Buhler, J., Eng, J. K., Bumgarner, R., Goodlett, D. R., Aebersold, R., & Hood, L. (2001) · Science · doi:10.1126/science.292.5518.929 · Cited by 2,050 · cited 1×
“This confluence of genomic and information technologies brings a powerful new approach to the study of biological systems, as exemplified by recent studie”
BackgroundDer, S. D., Zhou, A., Williams, B. R. G., & Silverman, R. H. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15623 · Cited by 1,816
A N EW A PPROACH TO D ECODING L IFE : Systems Biology
Ideker, T., Galitski, T., & Hood, L. (2001) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.2.1.343 · Cited by 1,664 · cited 1×
“Together, these technologies provide a global perspective on the complex interactions that occur between all levels of biological information ('systems biology'), from gene expression to protein productio”
Background
Research works printed but not linked: 7
- Biron, C. A. & Sen, G. C. in Fields Virology (eds Knipe, D. M. & Howley, P. M.) 321–352 (Lippincott, Williams & Wilkins, Philadelphia, 2001).
- Witherell, G. W. & Beineke, P. Statistical analysis of combined substitutions in nonstructural 5A region of hepatitis C virus and interferon response. J. Med. Virol. 63, 8–16 (2001). · doi:10.1002/1096-9071(200101)63:1<8::aid-jmv1001>3.0.co;2-k
- Sumpter, R. Jr & Gale, M. Jr. in American Society for Virology 21st Annual Meeting W33-3 (Lexington, Kentucky, 2002).
- Whitley, R. J. in Fields Virology (eds Knipe, D. M. & Howley, P. M.) 2461–2509 (Lippincott, Williams & Wilkins, Philadelphia, 2001).
- Roizman, B. & Knipe, D. M. in Fields Virology (eds Knipe, D. M. & Howley, P. M.) 2399–2460 (Lippincott, Williams & Wilkins, Philadelphia, 2001).
- Esposito, J. J. & Fenner, F. in Fields Virology (eds Knipe, D. M. & Howley, P. M.) 2849–2884 (Lippincott, Williams & Wilkins, Philadelphia, 2001).
- Moss, B. in Fields Virology (eds Knipe, D. M. & Howley, P. M.) 2885–2922 (Lippincott, Williams & Wilkins, Philadelphia, 2001).
Cited by
Items 701–800 of 1,000
Ahmed, M., Wang, F., Levin, A., Le, C., Eltayebi, Y., Houghton, M., Tyrrell, D. L., & Barakat, K. (2015) · Drug Discovery Today · doi:10.1016/j.drudis.2015.01.008 · Cited by 24
Rotavirus Antagonism of the Innate Immune Response
Arnold, M. M., & Patton, J. T. (2009) · Viruses · doi:10.3390/v1031035 · Cited by 23
“Viruses use a diverse array of approaches to counteract the host IFN-signaling pathway (see [101] and [102] for review).”
BackgroundSharma, L., Peng, X., Qing, H., Hilliard, B. K., Kim, J., Swaminathan, A., Tian, J., Israni-Winger, K., Zhang, C., Habet, V., et al. (2021) · Journal of Virology · doi:10.1128/jvi.01241-21 · Cited by 25
Krogvold, L., Leete, P., Mynarek, I. M., Russell, M. A., Gerling, I., Lenchik, N. I., Mathews, C. E., Richardson, S. J., Morgan, N. G., & Dahl‐Jørgensen, K. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.881997 · Cited by 25
Leon, C., Tokarev, A. A., Bouchnita, A., & Volpert, V. A. (2023) · Vaccines · doi:10.3390/vaccines11010127 · Cited by 27
Orthopoxvirus Zoonoses—Do We Still Remember and Are Ready to Fight?
Gieryńska, M. M., Szulc‐Dąbrowska, L., Struzik, J., Gregorczyk-Zboroch, K. P., Mielcarska, M. B., Toka, F. N., Schollenberger, A., & Biernacka, Z. (2023) · Pathogens · doi:10.3390/pathogens12030363 · Cited by 29
Rift Valley Fever Virus Nucleoprotein Triggers Autophagy to Dampen Antiviral Innate Immune Responses
Zhu, X., Guan, Z., Fang, Y., Zhang, Y., Guan, Z., Li, S., & Peng, K. (2023) · Journal of Virology · doi:10.1128/jvi.01814-22 · Cited by 24
“Type I interferon (IFN-I) responses act as the first line of host defense against viral infection through the upregulation of numerous IFN-stimulated genes (ISGs), which can inhibit viral infection through diverse mechanisms (15, 16).”
BackgroundAutoantibodies to Interferons in Infectious Diseases
Quirós-Roldán, E., Sottini, A., Signorini, S. G., Serana, F., Tiecco, G., & Imberti, L. (2023) · Viruses · doi:10.3390/v15051215 · Cited by 26
“They are potent cell growth regulators with immunomodulatory activity, but are best known for their antiviral activity [3].”
BackgroundMenachery, V. D., & Leib, D. A. (2009) · Journal of Virology · doi:10.1128/jvi.00888-09 · Cited by 27
“In recent years, viral research has focused on cellular recognition of pathogen-associated molecular patterns and subsequent IFN induction, leading to the discovery of Toll-like receptors (TLRs) and retinoic acid inducible gene 1 (RIG-I)-like sensing molecules (18).”
BackgroundLi, T., Wu, S., Zhang, H., Wang, Y., Luo, H., Zuo, X., & Xiao, X. (2015) · Inflammation · doi:10.1007/s10753-015-0117-1 · Cited by 25
“STAT1 is involved in the inflammatory reaction after viral infection and host defense against bacteria [23, 24].”
BackgroundA Model System for In Vitro Studies of Bank Vole Borne Viruses
Stoltz, M., Sundström, K. B., Hidmark, A. S., Tolf, C., Vene, S., Ahlm, C., Lindberg, A. M., Lundkvist, Å., & Klingström, J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028992 · Cited by 23
“Consequently, most pathogenic viruses have evolved countermeasures which can inhibit induction of IFNs, and/or can inhibit IFN-induced activation of antiviral responses in infected cells [12,13].”
BackgroundParvovirus evades interferon-dependent viral control in primary mouse embryonic fibroblasts
Mattei, L. M., Cotmore, S. F., Tattersall, P. J., & Iwasaki, A. (2013) · Virology · doi:10.1016/j.virol.2013.03.020 · Cited by 24
Cheng, X., & Kao, H. (2012) · BMC Genomics · doi:10.1186/1471-2164-13-453 · Cited by 26
Su, H., Yuan, G., & Su, J. (2016) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2016.03.007 · Cited by 23
Oh, J. E., Lee, M. S., Kim, Y.-J., & Lee, H. K. (2016) · Scientific Reports · doi:10.1038/srep19089 · Cited by 25
Influenza Viruses: An Introduction
Kawaoka, Y., & Neumann, G. (2012) · Methods in molecular biology · doi:10.1007/978-1-61779-621-0_1 · Cited by 25
The cellular response to herpes simplex virus type 1 (HSV-1) during latency and reactivation
Kent, J. R., & Fraser, N. (2005) · Journal of NeuroVirology · doi:10.1080/13550280591002405 · Cited by 23
“Interferon signaling is a common finding in response to a viral infection and studies of this response are fairly comprehensive (Katze et al, 2002).”
BackgroundInfluentialAlphaviruses: Host pathogenesis, immune response, and vaccine & treatment updates
Guerrero‐Arguero, I., Freitas, C. M. T., Weber, K. S., Berges, B. K., Robison, R. A., & Pickett, B. E. (2021) · Journal of General Virology · doi:10.1099/jgv.0.001644 · Cited by 29
Mešić, A., Jackson, E., Lalika, M., Koelle, D. M., & Patel, R. C. (2022) · PLOS Global Public Health · doi:10.1371/journal.pgph.0000231 · Cited by 25
“Before IFNs are expressed, the innate immune system detects the presence of chemical substances in pathogen structures or released by pathogens through an array of protein pattern-recognition receptors [2].”
BackgroundAfrican swine fever virus pA104R protein acts as a suppressor of type I interferon signaling
Chen, Q., Li, L., Guo, S., Liu, Z., Liu, L., Tan, C., Chen, H., & Wang, X. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1169699 · Cited by 27
“To effectively infect and replicate, viruses have, in turn, devised various strategies to combat the production of ISGs through the inhibition of the JAK/STAT pathway activated by IFN and antagonizing of host antiviral defenses (Katze et al., 2002; Goodbourn and Randall, 2009; Schulz and Mossman, 2016; García-Sastre,…”
BackgroundDelivery of gold nanoparticle-conjugated M2e influenza vaccine in mice using coated microneedles
Nesovic, L. D., Roach, C., Joshi, G. V., & Gill, H. S. (2023) · Biomaterials Science · doi:10.1039/d3bm00305a · Cited by 22
Type 1 interferons contribute to the clearance of senescent cell
Katlinskaya, Y. V., Carbone, C. J., Yu, Q., & Fuchs, S. Y. (2015) · Cancer Biology & Therapy · doi:10.1080/15384047.2015.1056419 · Cited by 25
“Cytokines that belong to the family of type I interferons (IFN, including IFNa and IFNb) play a major role in anti-viral defenses (reviewed in).(4) Furthermore, IFN were recently implicated in restricting the propagation of the long interspersed repetitive genetic elements.”
BackgroundInhibition of foot-and-mouth disease virus replication in vitro and in vivo by small interfering RNA
Pengyan, W., Yan, R., Guo, Z., & Chuangfu, C. (2008) · Virology Journal · doi:10.1186/1743-422x-5-86 · Cited by 22
“It therefore seems reasonable to propose that the extremely potent interferon system has displaced RNAi as the key defense against virus infection in mammalian cells [20].”
Chen, Y., Wang, C., Lin, S., Zhang, M., Li, S.-Y., & Xu, F. (2016) · Cytokine · doi:10.1016/j.cyto.2016.01.016 · Cited by 26
Xia, S., Wang, H., Hong, X., Lu, J., Xu, D., Jiang, Y., & Lu, L. (2018) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2018.02.043 · Cited by 22
Combating viral contaminants in CHO cells by engineering innate immunity
Chiang, A. W. T., Li, S., Kellman, B. P., Chattopadhyay, G., Zhang, Y., Kuo, C., Gutierrez, J. M., Ghazi, F., Schmeisser, H., Ménard, P., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-45126-x · Cited by 23
Mujtaba, M. G., Patel, C. B., Patel, R. A., Flowers, L. O., Burkhart, M. A., Waiboci, L. W., Martin, J. P., Haider, M. I., Ahmed, C. M. I., & Johnson, H. M. (2006) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00021-06 · Cited by 22
“Among viral infections in which a protective role for IFN- is clearly demonstrated are infection with hepatitis B virus, herpes simplex virus, lymphocytic choriomeningitis virus, and some poxviruses (1, 2, 8).”
BackgroundImmunomodulation and immunodeficiency
FOSTER, A. P. (2004) · Veterinary Dermatology · doi:10.1111/j.1365-3164.2004.00363.x · Cited by 22
Wang, M., Huang, Y., Huang, J., Zheng, J. L., & Qian, G. X. (2015) · Genetics and Molecular Research · doi:10.4238/2015.october.28.42 · Cited by 26
Audigé, A., Schlaepfer, E., Bonanomi, A., Joller, H., Knuchel, M. C., Weber, M., Nadal, D., & Speck, R. F. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.4.2687 · Cited by 22
“Furthermore, some of the analyzed cytokines are specifically produced by cell subsets, such as IL-2 by T cells (47, 48), IFN- by T cells, NK cells, or macrophages (49, 50).”
BackgroundEradication of murine norovirus from a mouse barrier facility.
Kastenmayer, R. J., Perdue, K. A., & Elkins, W. R. (2008) · PubMed Central · Cited by 22
Yewdell, J. W., Pierson, T. C., & Bennink, J. R. (2009) · Wiley eBooks · doi:10.1128/9781555815981.ch14 · Cited by 24
Cano, I., Collet, B., Pereira, C., Paley, R. K., van Aerle, R., Stone, D. M., & Taylor, N. (2016) · Veterinary Microbiology · doi:10.1016/j.vetmic.2016.02.012 · Cited by 21
“In turn, this triggers the intracellular IFN signalling pathway which eventually induces the expression of a large number of IFN-stimulated genes (ISGs) leading to an antiviral, antiproliferative and immunoregulatory state in the host cells (Katze et al., 2002).”
BackgroundViral dedication to vigorous destruction of interferon receptors
Xia, C., Anderson, P. E., & Hahm, B. (2018) · Virology · doi:10.1016/j.virol.2018.06.017 · Cited by 22
Viral MicroRNAs: Interfering the Interferon Signaling
Ahmad, I., Valverde, A. M., Siddiqui, H., Schaller, S. J., & Naqvi, A. R. (2020) · Current Pharmaceutical Design · doi:10.2174/1381612826666200109181238 · Cited by 23
Liu, H., Shi, B., Zhang, Z., Zhao, B. L., Zhao, G., Li, Y., & Nan, Y. (2020) · Viruses · doi:10.3390/v12091009 · Cited by 21
“All type I IFNs (hereafter referred to as IFNs) bind to ubiquitously expressed cell membrane-bound heterodimers composed of IFN-α receptor 1 (IFNAR1) and 2 (IFNAR2), then activate JAK/STAT pathways to trigger expression of IFNs-stimulated genes (ISGs) [16].”
BackgroundMa, C., Li, Y., Zong, Y., Velkov, T., Wang, C., Yang, X., Zhang, M., Jiang, Z., Sun, H., Tong, Q., et al. (2022) · PLoS Pathogens · doi:10.1371/journal.ppat.1010295 · Cited by 21
“This response establishes an antiviral state in both infected and neighboring cells by stimulating the expression of antiviral genes known as interferon-stimulated genes, including 20,50-oligoadenylate synthetase (OAS), myxovirus resistance protein 1 (Mx1) and interferon-stimulated gene 15 (ISG15) [19].”
BackgroundInfluentialVirus nanotechnology for intratumoural immunotherapy
Omole, A. O., Zhao, Z., Chang-Liao, S., de Oliveira, J. F. A., Boone, C. E., Sutorus, L., Sack, M., Varner, J. A., Fiering, S., & Steinmetz, N. F. (2024) · Nature Reviews Bioengineering · doi:10.1038/s44222-024-00231-z · Cited by 21
“This bacteriophage has been engineered to carry unmethylated CpG-dense DNA (a TLR9 agonist).”
InfluentialFredericksen, F., Carrasco, G., Villalba, M., & Olavarría, V. H. (2015) · Molecular Immunology · doi:10.1016/j.molimm.2015.08.010 · Cited by 21
Zohari, S., Munir, M., Metreveli, G., Belák, S., & Berg, M. (2010) · Virology Journal · doi:10.1186/1743-422x-7-376 · Cited by 23
The V Protein of Canine Distemper Virus Is Required for Virus Replication in Human Epithelial Cells
Otsuki, N., Nakatsu, Y., Kubota, T., Sekizuka, T., Seki, F., Sakai, K., Kuroda, M., Yamaguchi, R., & Takeda, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0082343 · Cited by 21
“A critical factor that determines the host range of paramyxoviruses is the ability of each virus to counteract the host IFN system [51–54].”
BackgroundMiura, A., Honma, R., Togashi, T., Yanagisawa, Y., Ito, E., Imai, J., Isogai, T., Goshima, N., Watanabe, S., & Nomura, N. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.11.041 · Cited by 21
hTERT Extends the Life of Human Fibroblasts without Compromising Type I Interferon Signaling
Smith, M. C., Goddard, E. T., Lanfranca, M. P., & Davido, D. J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0058233 · Cited by 22
“The IFN response is an innate antiviral pathway that, upon detection of viral molecular patterns, results in the production and release of the cytokine and type 1 IFN, IFN-b [21–23].”
BackgroundHepatitis C virus impairs TLR3 signaling and inhibits IFN-λ 1 expression in human hepatoma cell line
Wang, Y., Li, J., Wang, X., Li, Y., Zhou, Y., Thomas, R. M., & Ho, W. (2013) · Innate Immunity · doi:10.1177/1753425913478991 · Cited by 21
“Viral infections result in induction of interferons (IFNs) that are the key players in antiviral responses.(9) Induction of the IFN-based antiviral innate immunity depends on several Toll-like receptors (TLRs), i.”
BackgroundDrug abuse, innate immunity and hepatitis C virus
Zhang, T., Li, Y., & Ho, W. (2006) · Reviews in Medical Virology · doi:10.1002/rmv.508 · Cited by 24
Expression and biological activity of two types of interferon genes in medaka (Oryzias latipes)
Maekawa, S., Chiang, Y.-A., Hikima, J.-I., Sakai, M., Lo, C., Wang, H., & Aoki, T. (2015) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2015.11.036 · Cited by 21
Boye, L., Welsby, I., Lund, L. D., Goriely, S., & Frøkiær, H. (2016) · Immunology · doi:10.1111/imm.12650 · Cited by 22
Li, S., Li, L., Zhu, H., Shi, M., Fan, H., Gao, Y., Wang, X., Jiang, P., & Bai, J. (2020) · Veterinary Microbiology · doi:10.1016/j.vetmic.2020.108658 · Cited by 21
Long non-coding RNA LNC_000641 regulates pseudorabies virus replication
Fang, L., Gao, Y., Liu, X., Bai, J., Jiang, P., & Wang, X. (2021) · Veterinary Research · doi:10.1186/s13567-021-00922-0 · Cited by 21
“Type I interferons (IFNs), primarily IFN-α/β, are produced by host cells as “early” antiviral agents [17, 18] and are recognized as a critical part of the host innate immune response to virus infection.”
BackgroundGoswami, B. B., Kulka, M., Ngo, D., & Cebula, T. A. (2004) · Antiviral Research · doi:10.1016/j.antiviral.2004.02.004 · Cited by 21
In Silico Study of Plant Polyphenols' Interactions with VP24–Ebola Virus Matrix Protein
Pleško, S. (2015) · Acta chimica slovenica · doi:10.17344/acsi.2015.1505 · Cited by 21
Platis, D., & Foster, G. R. (2003) · Protein Expression and Purification · doi:10.1016/s1046-5928(03)00187-6 · Cited by 21
Kook, I., & Jones, C. (2016) · Virus Research · doi:10.1016/j.virusres.2016.06.007 · Cited by 23
Abe, K., Beer, J. C., Nguyen, T. T., Ariyapala, I. S., Holmes, T. H., Feng, W., Zhang, B., Kuo, D., Luo, Y., Ma, X.-J., et al. (2024) · The Journal of Immunology · doi:10.4049/jimmunol.2300729 · Cited by 21
“%) enabled Alamar to demonstrate statistically signi fi cant changes for IFNA2 in baseline and longitudinal comparisons, as expected for an antiviral response (19).”
DUSP4 modulates RIG-I- and STING-mediated IRF3-type I IFN response
Jiao, H., James, S. J., Png, C. W., Cui, C., Li, H., Li, L., Chia, W. N., Min, N., Li, W., Claser, C., et al. (2024) · Cell Death and Differentiation · doi:10.1038/s41418-024-01269-7 · Cited by 21
“It is also known that activation of MAPKs induces AP-1 transcriptional factor, which, together with IRF3 and NF κ B, to regulate the expression of type I IFNs [41].”
BackgroundVats, A., Gautam, D., Maharana, J., Chera, J. S., Kumar, S., Rout, P. K., Werling, D., & De, S. (2020) · Molecular Immunology · doi:10.1016/j.molimm.2020.03.004 · Cited by 20
Ghobadi, M. Z., Emamzadeh, R., Teymoori‐Rad, M., & Afsaneh, E. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1001070 · Cited by 20
Sertznig, H., Roesmann, F., Wilhelm, A., Heininger, D., Bleekmann, B., Elsner, C., Santiago, M. L., Schuhenn, J., Karakoese, Z., Benatzy, Y., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.935800 · Cited by 22
“Type I interferons (IFN-I), which, among others, include 12 individual IFNa subtypes and IFNb, play a crucial role in the early innate immune defense against viral infections including HIV-1 (1, 2).”
BackgroundManipulation of innate immune signaling pathways by SARS-CoV-2 non-structural proteins
Lu, Y., Michel, H. A., Wang, P., & Smith, G. L. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.1027015 · Cited by 24
“Type I IFNs upregulate the transcription of IFN-stimulate genes (ISGs) with promoters containing the IFN-stimulated response element (ISRE) leading to translation of ISG products (Katze et al., 2002).”
BackgroundToledo, J. R., Barrera, M., Farnós, O., Gómez, S., Rodríguez, M. P., Agüero, F., Ormazábal, V., Parra, N. C., Suárez-Amarán, L., & Sánchez, O. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.09.073 · Cited by 21
Interferon in the treatment of chronic hepatitis C: a drug caught between past and future
Vezali, E., Aghemo, A., & Colombo, M. (2011) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2011.552906 · Cited by 20
“Briefly, the subcutaneous administration of IFN-a triggers a cascade of intracellular reactions that activate numerous IFN-inducible genes [19], leading to the synthesis of IFN-induced proteins that are believed to inhibit virus multiplication within single cells.”
BackgroundSato, Y., Koshizuka, T., Ishibashi, K., Hashimoto, K., Ishioka, K., Ikuta, K., Yokota, S., Fujii, N., & Suzutani, T. (2017) · Microbiology and Immunology · doi:10.1111/1348-0421.12483 · Cited by 21
Emerging Roles of Autophagy and Inflammasome in Ehrlichiosis
Tominello, T. R., Oliveira, E., Hussain, S. S., Elfert, A., Wells, J. Z., Golden, B., & Ismail, N. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01011 · Cited by 26
Jimenez, O., Barros, M. H. M., Matteo, E. D., Lombardi, M. G., Preciado, M. V., Niedobitek, G., & Chabay, P. (2019) · Scientific Reports · doi:10.1038/s41598-019-49015-1 · Cited by 21
Guo, M., Li, F., Ji, J., Liu, Y., Liu, F., Zhao, Y., Li, J., Han, S., Wang, Q., & Ding, G. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106754 · Cited by 21
Host–Pathogen Interactions: A Biological Rendez-Vous of the Infectious Nonself and Danger Models?
Tournier, J., & Quesnel‐Hellmann, A. (2006) · PLoS Pathogens · doi:10.1371/journal.ppat.0020044 · Cited by 20
“VV further encodes N1L, a protein that associates with I-jB kinase complex and TRAF-family-member-associated NF-jB activator-binding kinase-1 for inhibition.”
BackgroundInfluentialTengvall, S., & Harandi, A. M. (2007) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2007.09.001 · Cited by 20
Morphine suppresses intracellular interferon-α expression in neuronal cells
Wan, Q., Wang, X., Wang, Y., Li, S., Wang, S.-H., & Ho, W. (2008) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2008.04.026 · Cited by 20
ACTIVATION OF COMMON ANTIVIRAL PATHWAYS CAN POTENTIATE INFLAMMATORY RESPONSES TO SEPTIC SHOCK
Doughty, L., Carlton, S., Galen, B. T., Cooma-Ramberan, I., Chung, C. S., & Ayala, A. (2006) · Shock · doi:10.1097/01.shk.0000223129.79759.74 · Cited by 21
“Expression of MHC II on macrophages is a marker of activation (37).”
BackgroundInterferon induction and suppression in swine testicle cells by porcine parvovirus and its proteins
Lin, W., Qiu, Z., Liu, Q., & Cui, S. (2012) · Veterinary Microbiology · doi:10.1016/j.vetmic.2012.11.032 · Cited by 20
Inhibition of Jak1-Dependent Signal Transduction in Airway Epithelial Cells Infected with Adenovirus
Shi, L., Ramaswamy, M., Manzel, L. J., & Look, D. C. (2007) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2007-0158oc · Cited by 20
Structural aspects of recently discovered viral deubiquitinating activities
Sulea, T. I., Lindner, H. A., & Menard, R. (2006) · Biological Chemistry · doi:10.1515/bc.2006.108 · Cited by 22
Tsai, Y., Kuang, W.-F., Lu, T.-Y., Kao, J., Lai, M., Liu, C., Chen, P., & Hwang, L. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.06.030 · Cited by 19
“However, viruses, including HCV, have been reported to counteract many aspects of the IFN signaling pathways and thus successfully evade the host innate immunity [5,6].”
BackgroundZhou, Z., Zhang, J., & Sun, L. (2013) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2013.12.002 · Cited by 19
He, H., Zhai, C., Mei, M., Rao, Y., Liu, Y., Wang, F., Ma, L., Jiang, Z., Zhang, G., & Li, Y. (2018) · Enzyme and Microbial Technology · doi:10.1016/j.enzmictec.2018.12.005 · Cited by 19
Bioorthogonal Engineered Virus-Like Nanoparticles for Efficient Gene Therapy
Bao, C., Duan, J., Xie, Y., Feng, X.-P., Cui, W., Chen, S., Li, P., Liu, Y., Wang, J., Wang, G., et al. (2023) · Nano-Micro Letters · doi:10.1007/s40820-023-01153-y · Cited by 23
“To verify the reduced immunogenicity of reBiosome compared to eBiosome in the blood, we performed an assessment using a comprehensive anti-virus response panel, consisting of chemokines (CCL5, CXCL10, CCL2, and CXCL1) that are involved in the chemotaxis of granulocytes and monocytes [33–36], interferons (IFN-α, IFNβ,…”
MethodYang, R., Du, Y., Zhang, M., Liu, Y., Feng, H., Liu, R., Yang, B., Xiao, J., He, P., & Niu, F. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1249731 · Cited by 25
Protein Quality Control Systems and ER Stress as Key Players in SARS-CoV-2-Induced Neurodegeneration
Gavilán, E., Medina-Guzman, R., Bahatyrevich-Kharitonik, B., & Ruano, D. (2024) · Cells · doi:10.3390/cells13020123 · Cited by 21
“The production of interferons under viral infection induces the expression of ERAD/UPS-related genes, enhancing the degradation of viral proteins [90,91].”
BackgroundKhalil, A. M., Nogales, A., Martínez‐Sobrido, L., & Mostafa, A. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2024.1357866 · Cited by 19
Katsoulidis, E., Sassano, A., Majchrzak-Kita, B., Carayol, N., Yoon, P., Jordan, A., Druker, B. J., Fish, E. N., & Platanias, L. C. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m706816200 · Cited by 20
Inhibition of STAT Pathway Impairs Anti-Hepatitis C Virus Effect of Interferon Alpha
Zhao, L., He, S.-F., Liu, Y., Zhao, P., Bian, Z., & Qi, Z. (2016) · Cellular Physiology and Biochemistry · doi:10.1159/000452526 · Cited by 19
Li, T., Ke, Z., Liu, W., Xiong, Y., Zhu, Y., & Liu, Y. (2019) · Viruses · doi:10.3390/v11050427 · Cited by 20
“production of cytokines, type I IFN, and natural killer (NK) cells [27].”
BackgroundOral Pharmacokinetics of a Chitosan-Based Nano- Drug Delivery System of Interferon Alpha
Imperiale, J. C., Schlachet, I., Lewicki, M., Sosnik, A., & Biglione, M. M. (2019) · Polymers · doi:10.3390/polym11111862 · Cited by 19
“Interferon alpha (IFNα) is a cytokine that exhibits a broad spectrum of antiviral, immunomodulatory, antiproliferative and antitumoral activities [2].”
BackgroundBoas, G. R. V., Rescia, V. C., Paes, M. M., Lavorato, S. N., de Magalhães-Filho, M. F., Cunha, M. S., Simões, R. D. C., de Lacerda, R. B., de Freitas-Júnior, R. S., Ramos, B. H. D. S., et al. (2020) · Molecules · doi:10.3390/molecules25184086 · Cited by 21
“The initial control of viral replication by type I interferons (IFN), complement system proteins and other innate immune mediators limit viral spread in the host during the early stages of the disease [52].”
BackgroundAdvances in the Development of Antiviral Compounds for Rotavirus Infections
Tohmé, M. J., & Delgui, L. R. (2021) · mBio · doi:10.1128/mbio.00111-21 · Cited by 22
“innate immune response is crucial in viral infections (45), the role of autophagy, an innate immune mechanism, in RV infection is still controversial (120–122).”
BackgroundSARS-CoV-2 and Coronavirus Disease Mitigation: Treatment Options, Vaccinations and Variants
Khamees, A., Bani-Issa, J., Zoubi, M. S. A., Qasem, T., Alarjah, M. I. A., Alawadin, S. A., Al‐Shami, K., Hussein, F. H., Hussein, E. I., Bashayreh, I. H., et al. (2022) · Pathogens · doi:10.3390/pathogens11020275 · Cited by 20
“Interferons function by modulation of immune responses and have been described to have antiviral effects [107].”
BackgroundTwo mink parvoviruses use different cellular receptors for entry into CRFK cells
Park, G. S., Best, S. M., & Bloom, M. E. (2005) · Virology · doi:10.1016/j.virol.2005.06.038 · Cited by 19
Rautsi, O., Lehmusvaara, S., Salonen, T., Häkkinen, K., Sillanpää, M., Hakkarainen, T., Heikkinen, S., Vähäkangas, E., Ylä‐Herttuala, S., Hinkkanen, A., et al. (2006) · The Journal of Gene Medicine · doi:10.1002/jgm.997 · Cited by 23
“factors (IRF)-3 and -7, that are essential in the synthesis of type I IFNs [5].”
BackgroundFimia, G. M., Evangelisti, C., Alonzi, T., Romani, M., Fratini, F., Paonessa, G., Ippolito, G., Tripodi, M., & Piacentini, M. (2004) · Journal of Virology · doi:10.1128/jvi.78.23.12809-12816.2004 · Cited by 19
“Most of the viruses have evolved molecular mechanisms to evade the IFN-mediated cellular response (22).”
BackgroundViral infections: their elusive role in regulating susceptibility to autoimmune disease
Flodström‐Tullberg, M. (2003) · Microbes and Infection · doi:10.1016/s1286-4579(03)00161-8 · Cited by 20
The Vaccinia Virus N1L Protein Influences Cytokine Secretion in Vitro after Infection
ZHANG, Z., Abrahams, M.-R., Hunt, L. A., Suttles, J., Marshall, W. R., Lahiri, D. K., & Kotwal, G. J. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1352.005 · Cited by 20
The Quest for an Efficacious Antiviral for Respiratory Syncytial Virus
Torrence, P. F., & Powell, L. D. (2002) · Antiviral chemistry & chemotherapy · doi:10.1177/095632020201300601 · Cited by 19
The "Histone Mimicry" by Pathogens
Schaefer, U., Ho, J., Prinjha, R. K., & Tarakhovsky, A. (2013) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2013.78.020339 · Cited by 20
“In turn, viruses can target the antiviral signaling events for the benefit of virus replication and long-term virus propagation (Katze et al. 2002; Garcia-Sastre and Biron 2006; Kawai and Akira 2006).”
BackgroundInfluentialOladunni, F. S., Sarkar, S., Reedy, S., Balasuriya, U. B. R., Horohov, D. W., & Chambers, T. M. (2019) · Journal of Virology · doi:10.1128/jvi.01342-19 · Cited by 18
“Most viral intruders are recognized by PRRs such as the TLRs, which initiate signaling cascades leading to type I IFN production (37).”
BackgroundSARS CoV-2 detected in neonatal stool remote from maternal COVID-19 during pregnancy
Jin, J. C., Ananthanarayanan, A., Brown, J. A., Rager, S. L., Bram, Y., Sanidad, K. Z., Amir, M., Baergen, R. N., Stuhlmann, H., Schwartz, R. E., et al. (2022) · Pediatric Research · doi:10.1038/s41390-022-02266-7 · Cited by 20
Thorne, A. J., Bansal, A., Necker‐Brown, A., Mostafa, M., Gao, A., Georgescu, A., Kooi, C., Leigh, R., & Newton, R. (2023) · PLoS ONE · doi:10.1371/journal.pone.0286783 · Cited by 22
“Conversely, and despite potential roles for these two BIRCs in cell fate determination during viral infections [27], the antiviral cytokine, IFNG [61,62], did not acutely induce expression of either BIRC2 or BIRC3.”
Zhu, L., Yang, X., Mou, C., & Yang, Q. (2016) · Veterinary Microbiology · doi:10.1016/j.vetmic.2016.12.031 · Cited by 27
“However, in the competition between virus and host cells, many viruses have evolved the ability to evade or suppress the antiviral immunity (Katze et al., 2002).”
BackgroundNew developments in antiviral therapy for chronic hepatitis B
Takkenberg, R. B., Weegink, C. J., Zaaijer, H. L., & Reesink, H. W. (2009) · Vox Sanguinis · doi:10.1111/j.1423-0410.2009.01282.x · Cited by 21
Wang, Y., Li, J., Wang, X., Ye, L., Zhou, Y., & Ho, W. (2013) · Journal of Viral Hepatitis · doi:10.1111/jvh.12040 · Cited by 18
Martin, D. L., Murali‐Krishna, K., & Tarleton, R. L. (2010) · Infection and Immunity · doi:10.1128/iai.00275-10 · Cited by 18
Metadata
- Authors
- Katze, M. G., He, Y., & Gale, M.
- Affiliations
- University of Washington (US)
- The University of Texas Southwestern Medical Center (US)
- Corresponding author
- Katze, Michael G.
- Venue
- Nature Reviews Immunology
- Published
- 2002-09-01
- Volume
- 2
- Issue
- 9
- Pages
- 675-687
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- OpenAlex
- W2079295092
- Cited by
- 1,419
- References
- 138
- Citations by year
- 2026: 30 · 2025: 62 · 2024: 89 · 2023: 82 · 2022: 67 · 2021: 48 · 2020: 35 · 2019: 30 · 2018: 23 · 2017: 38 · 2016: 41 · 2015: 40 · 2014: 55 · 2013: 58 · 2012: 55
- FWCI
- 6.49
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature reviews. Immunology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Health Sciences › Medicine › Epidemiology › Virology and Viral Diseases
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Keywords
- interferon, antiviral immunity, host-virus interaction, interferon-stimulated genes, viral evasion of host defense, influenza virus, hepatitis C virus, herpes simplex virus, vaccinia virus, antiviral drug targets
- MeSH terms
- Animals, Hepatitis C, Herpes Simplex, Humans, Interferon Type I, Membrane Glycoproteins, Orthomyxoviridae, Orthomyxoviridae Infections, Receptors, Cell Surface, Vaccinia, Vaccinia virus, Virus Diseases, Virus Replication, Hepacivirus, Simplexvirus, Computational Biology, Databases as Topic, Genomics, Drosophila Proteins, Toll-Like Receptors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.